{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:20:29Z","timestamp":1794313229720,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"crossref","award":["2024-2-5025"],"award-info":[{"award-number":["2024-2-5025"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2270824"],"award-info":[{"award-number":["2270824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Beijing Municipality","award":["7232153"],"award-info":[{"award-number":["7232153"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-91461-7","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:03:25Z","timestamp":1741179805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors and prediction model of metabolic disorders in adult patients with pituitary stalk interruption syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Deyue","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"5","key":"91461_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1530\/EJE-19-0168","volume":"181","author":"J Vergier","year":"2019","unstructured":"Vergier, J. et al. Diagnosis of endocrine disease: Pituitary stalk interruption syndrome: etiology and clinical manifestations. Eur. J. Endocrinol. 181(5), 199\u2013209 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"91461_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1148\/radiology.165.2.3659371","volume":"165","author":"L Fujisawa","year":"1987","unstructured":"Fujisawa, L. et al. Transection of the pituitary stalk: Development of an ectopic posterior lobe assessed with MRI. Radiology 165, 487\u2013489 (1987).","journal-title":"Radiology"},{"issue":"7","key":"91461_CR3","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1210\/jcem.84.7.5849","volume":"84","author":"S Chen","year":"1999","unstructured":"Chen, S., Le\u00e9ger, J., Garel, C., Hassan, M. & Czernichow, P. Growth hormone deficiency with ectopic neurohypophysis: anatomical variations and relationship between the visibility of the pituitary stalk asserted by magnetic resonance imaging and anterior pituitary function. J. Clin. Endocrinol. Metab. 84(7), 2408\u20132413 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"91461_CR4","doi-asserted-by":"publisher","first-page":"1338781","DOI":"10.3389\/fendo.2024.1338781","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Re-analysis of gene mutations found in pituitary stalk interruption syndrome and a new hypothesis on the etiology. Front. Endocrinol. 15, 1338781 (2024).","journal-title":"Front. Endocrinol."},{"issue":"6","key":"91461_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","volume":"22","author":"GC Farrell","year":"2007","unstructured":"Farrell, G. C., Chitturi, S., Lau, G. K. & Sollano, J. D. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J. Gastroenterol. Hepatol. 22(6), 775\u2013777 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"91461_CR6","first-page":"100","volume":"20","author":"E Vilar-Gomez","year":"2020","unstructured":"Vilar-Gomez, E. et al. Enhanced liver fibrosis score can be used to predict liver-related events in patients with nonalcoholic steatohepatitis and compensated cirrhosis. Clin. Gastroenterol. Hepatol. 20(1), 100\u2013110 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"91461_CR7","doi-asserted-by":"crossref","unstructured":"Wang, C.Z., Guo, L.L., Han, B.Y., Su, X., Guo, Q.H. & Mu, Y.M. Pituitary stalk interruption syndrome: from clinical findings to pathogenesis. J. Neuroendocrinol. 29(1) (2017).","DOI":"10.1111\/jne.12451"},{"issue":"1","key":"91461_CR8","first-page":"1896285","volume":"2016","author":"CZ Wang","year":"2016","unstructured":"Wang, C. Z. et al. Growth hormone therapy benefits pituitary stalk interruption syndrome patients with short stature: a retrospective study of 75 han chinese. Int. J. Endocrinol. 2016(1), 1896285 (2016).","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"91461_CR9","first-page":"5401738","volume":"2020","author":"CZ Wang","year":"2020","unstructured":"Wang, C. Z., Guo, L. L., Guo, Q. H. & Mu, Y. M. Nbpf9 gene may be involved in congenital hypopituitarism: A whole-genome study of a boy with pituitary stalk interruption syndrome and his family. Int. J. Endocrinol. 2020(1), 5401738 (2020).","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"91461_CR10","doi-asserted-by":"publisher","first-page":"53579","DOI":"10.1371\/journal.pone.0053579","volume":"8","author":"Q Guo","year":"2013","unstructured":"Guo, Q. et al. Pituitary stalk interruption syndrome in Chinese people: Clinical characteristic analysis of 55 cases. PLoS One 8(1), 53579 (2013).","journal-title":"PLoS One"},{"issue":"7","key":"91461_CR11","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1210\/jc.2003-031601","volume":"89","author":"J Svensson","year":"2004","unstructured":"Svensson, J. et al. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J. Clin. Endocrinol. Metab. 89(7), 3306\u20133312 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"91461_CR12","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. Mafld: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158(7), 1999\u201320141 (2020).","journal-title":"Gastroenterology"},{"issue":"11","key":"91461_CR13","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.eprac.2021.06.003","volume":"27","author":"SJ Kang","year":"2021","unstructured":"Kang, S. J. et al. High prevalence of nonalcoholic fatty liver disease among adolescents and young adults with hypopituitarism due to growth hormone deficiency. Endocr. Pract. 27(11), 1149\u20131155 (2021).","journal-title":"Endocr. Pract."},{"issue":"1","key":"91461_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0030-1265217","volume":"43","author":"JW Hong","year":"2011","unstructured":"Hong, J. W. et al. Metabolic parameters and nonalcoholic fatty liver disease in hypopituitary men. Horm. Metab. Res. 43(1), 48\u201354 (2011).","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"91461_CR15","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/cen.14732","volume":"97","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome. Clin. Endocrinol. 97(5), 612\u2013621 (2022).","journal-title":"Clin. Endocrinol."},{"issue":"8","key":"91461_CR16","doi-asserted-by":"publisher","first-page":"44136","DOI":"10.1371\/journal.pone.0044136","volume":"7","author":"L Xu","year":"2012","unstructured":"Xu, L. et al. Association between serum growth hormone levels and nonalcoholic fatty liver disease: A cross-sectional study. PLoS One 7(8), 44136 (2012).","journal-title":"PLoS One"},{"issue":"1","key":"91461_CR17","doi-asserted-by":"publisher","first-page":"34605","DOI":"10.1038\/srep34605","volume":"6","author":"H Nishizawa","year":"2016","unstructured":"Nishizawa, H. et al. Igf-i induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner. Sci. Rep. 6(1), 34605 (2016).","journal-title":"Sci. Rep."},{"issue":"9","key":"91461_CR18","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/hep4.1953","volume":"6","author":"I Doycheva","year":"2022","unstructured":"Doycheva, I., Erickson, D. & Watt, K. D. Growth hormone deficiency and nafld: An overlooked and underrecognized link. Hepatol. Commun. 6(9), 2227\u20132237 (2022).","journal-title":"Hepatol. Commun."},{"key":"91461_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.10.010","volume":"124","author":"D Kaltenecker","year":"2019","unstructured":"Kaltenecker, D. et al. Hepatic growth hormone-jak2-stat5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression. Cytokine 124, 154569 (2019).","journal-title":"Cytokine"},{"issue":"2","key":"91461_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbrc.2012.05.115","volume":"423","author":"H Nishizawa","year":"2012","unstructured":"Nishizawa, H. et al. Gh-independent igf-i action is essential to prevent the development of nonalcoholic steatohepatitis in a gh-deficient rat model. Biochem. Biophys. Res. Commun. 423(2), 295\u2013300 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"91461_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.6065\/apem.2017.22.3.189","volume":"22","author":"SY Jung","year":"2017","unstructured":"Jung, S. Y. et al. Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma. Ann. Pediatr. Endocrinol. Metab. 22(3), 189\u2013196 (2017).","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"91461_CR22","first-page":"1","volume":"1","author":"R Vareldzis","year":"2024","unstructured":"Vareldzis, R., Perez, A. & Reisin, E. Hyperuricemia: An intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension. Curr. Hypertens. Rep. 1, 1\u20139 (2024).","journal-title":"Curr. Hypertens. Rep."},{"key":"91461_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2015.11.026","volume":"29","author":"M Kanbay","year":"2016","unstructured":"Kanbay, M. et al. Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur. J. Intern. Med. 29, 3\u20138 (2016).","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"91461_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","volume":"9","author":"L Du","year":"2024","unstructured":"Du, L. et al. Hyperuricemia and its related diseases: Mechanisms and advances in therapy. Signal Transduct. Target. Ther. 9(1), 212 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"91461_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0517-x","volume":"26","author":"HC Chi","year":"2019","unstructured":"Chi, H. C. et al. Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases. J. Biomed. Sci. 26, 1\u201315 (2019).","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"91461_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cyto.2007.10.001","volume":"40","author":"P Iglesias","year":"2007","unstructured":"Iglesias, P. & D\u00edez, J. J. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 40(2), 61\u201370 (2007).","journal-title":"Cytokine"},{"issue":"7","key":"91461_CR27","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter, T. G. & Rinella, M. Nonalcoholic fatty liver disease 2020: The state of the disease. Gastroenterology 158(7), 1851\u20131864 (2020).","journal-title":"Gastroenterology"},{"issue":"9","key":"91461_CR28","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1089\/thy.2018.0664","volume":"29","author":"RA Sinha","year":"2019","unstructured":"Sinha, R. A. et al. Nonalcoholic fatty liver disease and hypercholesterolemia: Roles of thyroid hormones, metabolites, and agonists. Thyroid 29(9), 1173\u20131191 (2019).","journal-title":"Thyroid"},{"issue":"3","key":"91461_CR29","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1210\/en.2006-0836","volume":"148","author":"YY Liu","year":"2007","unstructured":"Liu, Y. Y. et al. A mutant thyroid hormone receptor $$\\alpha$$ antagonizes peroxisome proliferator-activated receptor $$\\alpha$$ signaling in vivo and impairs fatty acid oxidation. Endocrinology 148(3), 1206\u20131217 (2007).","journal-title":"Endocrinology"},{"issue":"7","key":"91461_CR30","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1172\/JCI60580","volume":"122","author":"RA Sinha","year":"2012","unstructured":"Sinha, R. A. et al. Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J. Clin. Investig. 122(7), 2428\u20132438 (2012).","journal-title":"J. Clin. Investig."},{"issue":"18","key":"91461_CR31","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.12998\/wjcc.v10.i18.6211","volume":"10","author":"XY Zhang","year":"2022","unstructured":"Zhang, X. Y., Yuan, K., Fang, Y. L. & Wang, C. L. Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report. World J. Clin. Cases 10(18), 6211 (2022).","journal-title":"World J. Clin. Cases"},{"issue":"1","key":"91461_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.6065\/apem.2018.23.1.51","volume":"23","author":"D Jung","year":"2018","unstructured":"Jung, D. et al. Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: A case report. Ann. Pediatr. Endocrinol. Metab. 23(1), 51\u201355 (2018).","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"91461_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G. et al. A guide to machine learning for biologists. Nat. Rev. Mol. Cell Biol. 23(1), 40\u201355 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91461-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91461-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91461-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:28:52Z","timestamp":1741220932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-91461-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["91461"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-91461-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The principles of the Helsinki declaration were strictly adhered to during the implementation of this study, and the Committee on Human Research of the Chinese People\u2019s Liberation Army General Hospital approved the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"7740"}}